Viewing Study NCT01106066


Ignite Creation Date: 2025-12-24 @ 4:01 PM
Ignite Modification Date: 2026-02-01 @ 12:00 AM
Study NCT ID: NCT01106066
Status: TERMINATED
Last Update Posted: 2013-06-14
First Post: 2010-04-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I/II Study of Neoadjuvant Chemoradiotherapy With S-1/ Oxaliplatin in Patients With Gastric Cancer: Randomized Phase II Study of S-1/RT vs. S-1/Oxaliplatin/RT
Sponsor: Samsung Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Phase I: To Determine the Maximum Tolerated Dose (MTD) View
None Phase II: To Assess the Pathologic CR Rate and Feasibility … View
Keywords: